Drug Discovery and Development, Drug Development

Drug Discovery and Development, Drug Development

4.11 - 1251 ratings - Source

From first principles to real-world applications-here is the first comprehensive guide to drug discovery and development Modern drug discovery and development require the collaborative efforts of specialists in a broadarray of scientific, technical, and business disciplines-from biochemistry to molecular biology, organic chemistry to medicinal chemistry, pharmacology to marketing. Yet surprisingly, until now, there were no authoritative references offering a complete, fully integrated picture of the process. The only comprehensive guide of its kind, this groundbreaking two-volume resource provides an overview of the entire sequence of operations involved in drug discovery and develop-?ment-from initial conceptualization to commercialization to clinicians and medical practitioners. Volume 1: Drug Discovery describes all the steps in the discovery process, including conceptualizing a drug, creating a library of candidates for testing, screening candidates for in vitro and in vivo activity, conducting and analyzing the results of clinical trials, and modifying a drug as necessary. Volume 2: Drug Development delves into the nitty-gritty details of optimizing the synthetic route, drug manufacturing, outsourcing, and marketing-including drug coloring and delivery methods. Featuring contributions from a world-class team of experts, Drug Discovery and Development: Features fascinating case studies, including the discovery and development of erythromycin analogs, Tagamet, and Ultiva (remifentanil) Discusses the discovery of medications for bacterial infections, Parkinson's disease, psoriasis, peptic ulcers, atopic dermatitis, asthma, and cancer Includes chapters on combinatorial chemistry, molecular biology-based drug discovery, genomics, and chemogenomics Drug Discovery and Development is an indispensable working resource for industrial chemists, biologists, biochemists, and executives who work in the pharmaceutical industry.20.4 HOW INDUSTRIALLY READY TECHNOLOGY CAN DELIVER COMMERCIAL ADVANTAGES Having industrially ready technology ... Because of the high attrition rate in the pharmaceutical pipeline, wherein only a small proportion of drug candidates will eventually make it to the market, there is a tendency for ... Scheme 20.17 represents the synthesis of L- or D-amino acids of the arylalanine type.

Title:Drug Discovery and Development, Drug Development
Author:Mukund S. Chorghade
Publisher:John Wiley & Sons - 2007-02-16


You Must CONTINUE and create a free account to access unlimited downloads & streaming